In contrast, patients with insufficient expression of SORBS2, PAM, ZFAT, DOCK7, ERMAP, BTF3, and GUSB in the tumor tissues had shorter survival duration than patients in the high-expression group. The gene discussed is SORBS2; the disease is neoplasm.